ACAD have specifically stated the $250US may be used for growth assets…..
it’s in their NASDAQ Ann regarding the cap raise. I realised after posting it didn’t say growth but it did mention acquisitions.
Ah… you’re referring to the statements about use of proceeds, included in the prospectus and prospectus supplement for Acadia’s recent cap raise.
The Offering - Use of Proceeds
We intend to use the net proceeds of this offering for general corporate purposes, including to fund preparations for the potential commercialization of pimavanserin for the treatment of dementia-related psychosis, if approved for such indication, and working capital. See “Use of Proceeds”
Use of Proceeds
We intend to use the net proceeds from this offering for general corporate purposes, including to fund preparations for the potential commercialization of pimavanserin for the treatment of dementia-related psychosis, if approved for such indication, and working capital. We may also use a portion of the net proceeds to acquire or invest in complementary businesses, products and technologies. Although we currently have no specific agreements, commitments or understandings with respect to any acquisition or investment, we evaluate acquisition and investment opportunities and may engage in related discussions with other companies from time to time.
I’m not sure how this can be read as a specific statement that US$250m may be used for growth assets.
NEU Price at posting:
$2.00 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)